Argitalpenak (150) Ciro Casanova Macario argitalpenak

2024

  1. Association between occupational exposure and chronic obstructive pulmonary disease and respiratory symptoms in the Spanish population

    Archivos de Bronconeumologia, Vol. 60, Núm. 1, pp. 16-22

  2. Home noninvasive ventilation in severe COPD: in whom does it work and how?

    ERJ Open Research, Vol. 10, Núm. 1

  3. Impact of Applying the Global Lung Initiative Criteria for Airway Obstruction in GOLD Defined COPD Cohorts: The BODE and CHAIN Experience

    Archivos de Bronconeumologia, Vol. 60, Núm. 1, pp. 10-15

  4. Oxidative Damage and Telomere Length as Markers of Lung Cancer Development among Chronic Obstructive Pulmonary Disease (COPD) Smokers

    Antioxidants, Vol. 13, Núm. 2, pp. 156

2023

  1. Circulating levels of mitochondrial oxidative stress-related peptides MOTS-c and Romo1 in stable COPD: A cross-sectional study

    Frontiers in Medicine, Vol. 10

  2. Circulating miR-206 and miR-1246 as Markers in the Early Diagnosis of Lung Cancer in Patients with Chronic Obstructive Pulmonary Disease

    International Journal of Molecular Sciences, Vol. 24, Núm. 15

  3. Eosinophil Subtypes in Adults with Asthma and Adults with Chronic Obstructive Pulmonary Disease

    American journal of respiratory and critical care medicine, Vol. 208, Núm. 2, pp. 155-162

  4. Metallomic Signatures of Lung Cancer and Chronic Obstructive Pulmonary Disease

    International Journal of Molecular Sciences, Vol. 24, Núm. 18

  5. Tobacco Patterns and Risk of Chronic Obstructive Pulmonary Disease: Results From a Cross-Sectional Study

    Archivos de Bronconeumologia, Vol. 59, Núm. 11, pp. 717-724

2022

  1. ANTES Program: One Year on

    Archivos de Bronconeumologia

  2. Associations between serum mitokine levels and outcomes in stable COPD: an observational prospective study

    Scientific Reports, Vol. 12, Núm. 1

  3. Associations of serum sclerostin levels with body composition, pulmonary function, and exacerbations in COPD patients

    Pulmonology

  4. Chest CT-assessed comorbidities and all-cause mortality risk in COPD patients in the BODE cohort

    Respirology, Vol. 27, Núm. 4, pp. 286-293

  5. Comorbidities and mortality risk in adults younger than 50 years of age with chronic obstructive pulmonary disease

    Respiratory Research, Vol. 23, Núm. 1

  6. Determinants of blood eosinophil levels in the general population and patients with COPD: a population-based, epidemiological study

    Respiratory Research, Vol. 23, Núm. 1

  7. Respiratory symptoms and their determinants in the general Spanish population: changes over 20 years

    ERJ Open Research, Vol. 8, Núm. 4

  8. Spanish COPD Guidelines (GesEPOC) 2021 Update Diagnosis and Treatment of COPD Exacerbation Syndrome

    Archivos de Bronconeumologia, Vol. 58, Núm. 2, pp. 159-170

  9. Spanish COPD Guidelines (GesEPOC) 2021: Updated Pharmacological treatment of stable COPD

    Archivos de Bronconeumologia, Vol. 58, Núm. 1, pp. 69-81

  10. The 7 Cardinal Sins of COPD in Spain

    Archivos de Bronconeumologia

  11. [Translated article] ANTES Program: One Year on

    Archivos de Bronconeumologia